Purple Biotech Ltd.
PPBT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001614744
No open-market purchases or sales by Purple Biotech Ltd. insiders were filed in the last 90 days; 13 institutions reported holding it in 13F filings for Q2 2026, worth $141.0K in total; no superinvestor holds it.
Holders of 5% or more of PPBT
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Purple Biotech Ltd., largest stake first. The change is against the holder's previous filing.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
5 Schedule 13D and 13G filings on Purple Biotech Ltd., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Nov 7, 20255:29 PM ET | Intracoastal Capital, LLCand 2 others | 13G/A | 9.99%200.5M shares | 0.00 ppfrom 9.99% | Sep 30, 2025 | SEC |
| Sep 10, 20256:55 PM ET | Intracoastal Capital, LLCand 2 others | 13G | 9.99%139.6M shares | New | Sep 4, 2025 | SEC |
| Sep 9, 20254:47 PM ET | Lincoln Alternative Strategies LLC | 13G | 9.90%605.0K shares | New | Sep 4, 2025 | SEC |
| Sep 9, 20254:24 PM ET | Orca Capital AG | 13G/A | 4.90%306.4K shares | −5.00 ppfrom 9.90%Below 5% | Sep 4, 2025 | SEC |
| Sep 9, 20254:18 PM ET | Orca Capital AG | 13G | 9.90%605.0K shares | New | Sep 4, 2025 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Purple Biotech Ltd. shares.
No Form 144 notices for Purple Biotech Ltd. are on file.